U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C17H13ClN4
Molecular Weight 308.765
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LIAROZOLE

SMILES

ClC1=CC=CC(=C1)C(N2C=CN=C2)C3=CC=C4N=CNC4=C3

InChI

InChIKey=UGFHIPBXIWJXNA-UHFFFAOYSA-N
InChI=1S/C17H13ClN4/c18-14-3-1-2-12(8-14)17(22-7-6-19-11-22)13-4-5-15-16(9-13)21-10-20-15/h1-11,17H,(H,20,21)

HIDE SMILES / InChI

Molecular Formula C17H13ClN4
Molecular Weight 308.765
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Approval Year

Substance Class Chemical
Created
by admin
on Fri Dec 15 16:03:56 UTC 2023
Edited
by admin
on Fri Dec 15 16:03:56 UTC 2023
Record UNII
K0Q29TGV9Y
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LIAROZOLE
INN   MART.   MI   WHO-DD  
INN  
Official Name English
LIAROZOLE [MI]
Common Name English
1H-BENZIMIDAZOLE, 5-((3-CHLOROPHENYL)-1H-IMIDAZOL-1-YLMETHYL)-, (±)-
Systematic Name English
liarozole [INN]
Common Name English
(±)-5-(M-CHLORO-.ALPHA.-IMIDAZOL-1-YLBENZYL)BENZIMIDAZOLE
Systematic Name English
6-((3-CHLOROPHENYL)-1H-IMIDAZOL-1-YLMETHYL)-1H-BENZIMIDAZOLE
Common Name English
LIAROZOLE [MART.]
Common Name English
Liarozole [WHO-DD]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C2018
Created by admin on Fri Dec 15 16:03:56 UTC 2023 , Edited by admin on Fri Dec 15 16:03:56 UTC 2023
FDA ORPHAN DRUG 183904
Created by admin on Fri Dec 15 16:03:56 UTC 2023 , Edited by admin on Fri Dec 15 16:03:56 UTC 2023
EU-Orphan Drug EU/3/03/144
Created by admin on Fri Dec 15 16:03:56 UTC 2023 , Edited by admin on Fri Dec 15 16:03:56 UTC 2023
Code System Code Type Description
SMS_ID
100000077092
Created by admin on Fri Dec 15 16:03:56 UTC 2023 , Edited by admin on Fri Dec 15 16:03:56 UTC 2023
PRIMARY
ChEMBL
CHEMBL389433
Created by admin on Fri Dec 15 16:03:56 UTC 2023 , Edited by admin on Fri Dec 15 16:03:56 UTC 2023
PRIMARY
MESH
C061121
Created by admin on Fri Dec 15 16:03:56 UTC 2023 , Edited by admin on Fri Dec 15 16:03:56 UTC 2023
PRIMARY
NCI_THESAURUS
C1433
Created by admin on Fri Dec 15 16:03:56 UTC 2023 , Edited by admin on Fri Dec 15 16:03:56 UTC 2023
PRIMARY
CAS
115575-11-6
Created by admin on Fri Dec 15 16:03:56 UTC 2023 , Edited by admin on Fri Dec 15 16:03:56 UTC 2023
PRIMARY
EVMPD
SUB14356MIG
Created by admin on Fri Dec 15 16:03:56 UTC 2023 , Edited by admin on Fri Dec 15 16:03:56 UTC 2023
PRIMARY
INN
6478
Created by admin on Fri Dec 15 16:03:56 UTC 2023 , Edited by admin on Fri Dec 15 16:03:56 UTC 2023
PRIMARY
DRUG BANK
DB13066
Created by admin on Fri Dec 15 16:03:56 UTC 2023 , Edited by admin on Fri Dec 15 16:03:56 UTC 2023
PRIMARY
MERCK INDEX
m6798
Created by admin on Fri Dec 15 16:03:56 UTC 2023 , Edited by admin on Fri Dec 15 16:03:56 UTC 2023
PRIMARY Merck Index
WIKIPEDIA
Liarozole
Created by admin on Fri Dec 15 16:03:56 UTC 2023 , Edited by admin on Fri Dec 15 16:03:56 UTC 2023
PRIMARY
PUBCHEM
60652
Created by admin on Fri Dec 15 16:03:56 UTC 2023 , Edited by admin on Fri Dec 15 16:03:56 UTC 2023
PRIMARY
FDA UNII
K0Q29TGV9Y
Created by admin on Fri Dec 15 16:03:56 UTC 2023 , Edited by admin on Fri Dec 15 16:03:56 UTC 2023
PRIMARY
EPA CompTox
DTXSID9048277
Created by admin on Fri Dec 15 16:03:56 UTC 2023 , Edited by admin on Fri Dec 15 16:03:56 UTC 2023
PRIMARY
Related Record Type Details
ENANTIOMER -> RACEMATE
ENANTIOMER -> RACEMATE
TARGET -> INHIBITOR
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY